NMPA Approval

Ibuprofen and Pseudoephedrine HCL Sustained Release Capsules

Approval Number

国药准字H20051079

Company中美天津史克制药有限公司

Registration Date

April 7, 2020

Drug Information

Generic Name

布洛伪麻缓释胶囊

Dosage Form

胶囊剂

Strength

每粒胶囊含布洛芬300mg,盐酸伪麻黄碱45mg。

Drug Type

化学药品

Registration Date

April 7, 2020

Company Information

Applicant Company

Company Name中美天津史克制药有限公司

Manufacturing Company

Company Name中美天津史克制药有限公司

Company Address

天津市东丽区程林庄道澄州路口

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

布洛伪麻缓释胶囊 - NMPA 批准文号 | MedPath